Cargando…

TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer

Tamoxifen is the most widely used hormone therapy in estrogen receptor-positive (ER+) breast cancer, which accounts for approximately 70% of all breast cancers. Although patients who receive tamoxifen therapy benefit with respect to an improved overall prognosis, resistance and cancer recurrence sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ming-Yang, Huang, Hsin-Yi, Kuo, Yao-Lung, Lo, Chiao, Sun, Hung-Yu, Lyu, Yu-Jhen, Chen, Bo-Rong, Li, Jie-Ning, Chen, Pai-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406945/ https://www.ncbi.nlm.nih.gov/pubmed/30759864 http://dx.doi.org/10.3390/cancers11020210

Ejemplares similares

TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer
por: Li, Jie-Ning, et al.
Publicado: (2021)

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
por: Lai, Hui‐Huang, et al.
Publicado: (2019)

SUMOylation of TARBP2 regulates miRNA/siRNA efficiency
por: Chen, Cheng, et al.
Publicado: (2015)

Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer
por: Oi, Ryoko, et al.
Publicado: (2016)

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
por: Caramuta, Stefano, et al.
Publicado: (2013)

Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
por: Li, Li-Man, et al.
Publicado: (2021)

TaRBP1 stabilizes TaGLTP and negatively regulates stripe rust resistance in wheat
por: Li, Yue, et al.
Publicado: (2023)

Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
por: Li, Li-Man, et al.
Publicado: (2021)

Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance
por: Ye, Jingmei, et al.
Publicado: (2018)

LINC01526 Promotes Proliferation and Metastasis of Gastric Cancer by Interacting with TARBP2 to Induce GNG7 mRNA Decay
por: Zhou, Jin-Yong, et al.
Publicado: (2022)

TARBP2 promotes tumor angiogenesis and metastasis by destabilizing antiangiogenic factor mRNAs
por: Zhou, Meicen, et al.
Publicado: (2021)

Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
por: Chang, Yung-Chieh, et al.
Publicado: (2020)

Expression of SnoRNA U50A Is Associated with Better Prognosis and Prolonged Mitosis in Breast Cancer
por: Li, Jie-Ning, et al.
Publicado: (2021)

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer
por: Su, Chih-Ming, et al.
Publicado: (2016)

Functional Redundancy of DICER Cofactors TARBP2 and PRKRA During Murine Embryogenesis Does Not Involve miRNA Biogenesis
por: Pullagura, Sri Ramulu N., et al.
Publicado: (2018)

Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
por: Lin, Yu-Ling, et al.
Publicado: (2016)

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
por: Liu, Chien-Ming, et al.
Publicado: (2015)

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
por: Kuo, Sung-Hsin, et al.
Publicado: (2023)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity
por: Li, Jie-Ning, et al.
Publicado: (2021)

Hypoxia-induced let-7f-5p/TARBP2 feedback loop regulates osteosarcoma cell proliferation and invasion by inhibiting the Wnt signaling pathway
por: Chen, Guangnan, et al.
Publicado: (2020)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
por: Yang, Li-Heng, et al.
Publicado: (2012)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
por: Zhang, Hongkai, et al.
Publicado: (2020)

TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment
por: Ning, Hao, et al.
Publicado: (2022)

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
por: Ma, Ji, et al.
Publicado: (2014)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

CSC-3436 switched tamoxifen-induced autophagy to apoptosis through the inhibition of AMPK/mTOR pathway
por: Wu, Sheng-Tang, et al.
Publicado: (2016)

Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation
por: Huang, Han Hsiang, et al.
Publicado: (2016)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
por: Brüning, Ansgar, et al.
Publicado: (2010)

Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
por: Tsai, Chia-Lung, et al.
Publicado: (2013)

HSD3B1 Expression Is Upregulated by Interleukin 4 in HT-29 Colon Cancer Cells via Multiple Signaling Pathways
por: Chen, Hsin-Mei, et al.
Publicado: (2022)

An Approach to Enhance Dissolution Rate of Tamoxifen Citrate
por: SreeHarsha, Nagaraja, et al.
Publicado: (2019)

Enhancing Cytotoxicity of Tamoxifen Using Geranium Oil
por: Mizuno, Dai, et al.
Publicado: (2022)

Impact of Irradiation on the Pharmacokinetics and Biotransformation of Tamoxifen
por: Cheng, Yung-Yi, et al.
Publicado: (2022)

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen
por: CHEN, MING, et al.
Publicado: (2013)

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
por: Lü, Mingrong, et al.
Publicado: (2015)

The learning curve of endoscopic total mastectomy in Taiwan: A multi-center study
por: Hung, Chin-Sheng, et al.
Publicado: (2017)

Correction: The learning curve of endoscopic total mastectomy in Taiwan: A multi-center study
por: Hung, Chin-Sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_trsilf75b7gttd458ucohsrqb9